ATRA
Atara Biotherapeutics Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website atarabio.com
- Employees(FY) 334
- ISIN US0465131078
Performance
+11.76%
1W
-10.5%
1M
-20.84%
3M
+26.95%
6M
+18.95%
YTD
-70.39%
1Y
Profile
Atara Biotherapeutics, Inc. develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as nasopharyngeal carcinoma. Its CAR T immunotherapy pipeline products include ATA2271 and ATA3271 to treat mesothelin; and ATA3219 for the treatment of B-cell malignancies, as well as ATA188 that is in Phase 2 clinical trials to treat multiple sclerosis. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center. The company was incorporated in 2012 and is headquartered in Thousand Oaks, California.
Technical Analysis of ATRA 2024-05-10
Overview:
In analyzing the technical indicators for ATRA over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-09 10:57
- 2024-05-09 05:15
- 2024-05-09 04:17
Atara Biotherapeutics: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-09 04:01
- 2024-05-03 04:01
- 2024-04-05 04:01
- 2024-03-28 01:53
- 2024-03-27 21:40
- 2024-03-27 20:40
Atara Biotherapeutics: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-27 20:30
- 2024-02-28 20:05
- 2024-02-28 03:30
- 2024-02-13 20:00
- 2024-01-31 05:30
- 2024-01-10 12:26
Seth Klarman's Exit from Atara Biotherapeutics Inc(Yahoo Finance)
- 2024-01-10 12:26
Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding(Yahoo Finance)
- 2024-01-07 20:00
- 2024-01-07 19:00
- 2024-01-04 03:01
- 2023-12-20 03:01
- 2023-12-10 23:00
- 2023-12-01 03:01
- 2023-11-29 05:05
- 2023-11-23 23:29
- 2023-11-22 03:01
- 2023-11-21 20:14
Billionaire Seth Klarmans Biotech Stock Picks(Yahoo Finance)
- 2023-11-10 03:01
- 2023-11-08 19:23
Why Is Atara Biotherapeutics (ATRA) Stock Down 50% Today?(Investorplace)
- 2023-11-08 17:40
Ataras cell therapy approach to MS falls short in study(Yahoo Finance)
- 2023-11-08 04:35
Page 1 of 4
previousnext